Autor: |
Cree Ian A, Johnson Penny, Stacey Bernard SF, Mehta Raj L, Bateman Adrian C, Bhandari Pradeep, Di Nicolantonio Federica, Patel Praful |
Jazyk: |
angličtina |
Rok vydání: |
2006 |
Předmět: |
|
Zdroj: |
BMC Cancer, Vol 6, Iss 1, p 134 (2006) |
Druh dokumentu: |
article |
ISSN: |
1471-2407 |
DOI: |
10.1186/1471-2407-6-134 |
Popis: |
Abstract Background COX-2 expression in tumour cells has been associated with poor prognosis in gastrointestinal and non-gastrointestinal cancers. The aim of our study was to test the hypothesis that higher levels of COX-2 expression are prognostically related to poor clinico-pathologic features in adenocarcinoma of the oesophagus. Methods We reviewed the records of 100 consecutive patients undergoing resection for adenocarcinoma of the oesophagus to collect data on T-stage, N-stage, tumour recurrence and survival. T & N-stage was further confirmed by histological examination. COX-2 protein expression was assessed by immunohistochemistry in all patients and COX-2 m-RNA expression was measured by quantitative RT-PCR in a small group of patients. Results Higher levels of COX-2 expression were associated with higher T stage (p = 0.008), higher N stage (p = 0.049), increased risk of tumour recurrence (p = 0.01) and poor survival (p = 200 was associated with a median survival of 10 months compared to 26 months with a score of Conclusion Higher levels of COX-2 expression are associated with poor clinico-pathologic features and poor survival in patients with oesophageal adenocarcinoma. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|